Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
Regulatory changes in the US and UK to watch in 2024
Clinical Trials Arena December 19, 2023
The life sciences sector is set to see a significant amount of change in 2024.
Significant regulatory changes across numerous medical fields are coming in 2024 with pharmaceutical and medical device companies urged to be ready for a year of legal alterations.
From the UK’s reworking of the Voluntary Scheme for Branded Medicines (VPAS) and delayed plans to introduce a new medical device validation scheme, to the United States’ attempt to regulate products that utilise artificial intelligence (AI), 2024 is set to be a busy year for healthcare regulators.
US – Regulating LDTs
Chief among US legal changes set to come into effect in 2024 that has raised concern is the Food and Drug Administration’s (FDA) plan to regulate laboratory-developed...
Today's Sponsors
Today's Sponsor